Literature DB >> 31364882

Non-medical switching: save today and pay tomorrow.

Maurizio Benucci1, Fabrizio Cantini2.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31364882     DOI： 10.1080/13696998.2019.1651132

Source DB:  PubMed          Journal:  J Med Econ        ISSN： 1369-6998            Impact factor:   2.448


× No keyword cloud information.
  3 in total

1.  The switch from etanercept originator to SB4: data from a real-life experience on tolerability and persistence on treatment in joint inflammatory diseases.

Authors:  Cosimo Bruni; Stefano Gentileschi; Giovanni Pacini; Caterina Baldi; Marco Capassoni; Lorenzo Tofani; Marco Bardelli; Laura Cometi; Luca Cantarini; Francesca Nacci; Michele Vietri; Francesca Bartoli; Ginevra Fiori; Bruno Frediani; Marco Matucci-Cerinic
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-10-13       Impact factor: 5.346

Review 2.  The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable.

Authors:  Anita Afzali; Daniel Furtner; Richard Melsheimer; Philip J Molloy
Journal:  Adv Ther       Date:  2021-03-21       Impact factor: 3.845

3.  Uptake of Trastuzumab Biosimilars for the Treatment of HER2-Positive Breast Cancer: A Real-World Experience from a Cancer Center.

Authors:  Michela Piezzo; Roberta D'Aniello; Ilaria Avallone; Bruno Barba; Daniela Cianniello; Stefania Cocco; Antonio D'Avino; Germira Di Gioia; Vincenzo Di Lauro; Giuseppina Fusco; Raffaele Piscitelli; Claudia von Arx; Michelino De Laurentiis; Piera Maiolino
Journal:  Pharmaceutics       Date:  2021-05-10       Impact factor: 6.321
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.